How globalization and market innovation challenge how we think about and respond to drug use: ‘Spice’ a case study-Reference-Cited by-同舟云学术

How globalization and market innovation challenge how we think about and respond to drug use: ‘Spice’ a case study

Published:2010-06 Issue:6 Volume:105 Page:951-953
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:

Author:

GRIFFITHS PAUL,SEDEFOV ROUMEN,GALLEGOS ANA,LOPEZ DOMINIQUE

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1360-0443.2009.02874.x/fullpdf

Reference12 articles.

1. Early Warning System http://www.emcdda.europa.eu/themes/new-drugs/early-warning

2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Thematic Papers-Understanding the ‘Spice’ Phenomenon 2009 http://www.emcdda.europa.eu/html.cfm/index90917EN.html

3. Spice and other herbal blends: harmless incense or cannabinoid designer drugs?;Auwärter;J Mass Spectrom,2009

4. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents;Compton;J Pharmacol Exp Ther,1992

5. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities;Compton;J Pharmacol Exp Ther,1993

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ‘Spice’ Use Motivations, Experiences, and Repercussions among Veterans of the United States Armed Forces;Substance Use & Misuse;2024-03-28

2. Autopsy, histological and toxicological findings in deaths associated with new psychoactive substances (NPS): a study with 12 autopsies;Forensic Science International: Reports;2023-12

3. Assessment of the severity of the condition of patients with acute substance poisoning using the PSS scale;HIV Infection and Immunosuppressive Disorders;2023-04-30

4. The psychedelic renaissance: a case of outlaw user innovation in the pharmaceutical industry;Prometheus;2023

5. Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators;Cannabis and Cannabinoid-Based Medicines in Cancer Care;2022